Well-differentiated pancreatic neuroendocrine tumours: a single-institution experience

被引：0
|
作者：
Perez Casanova, L. [1 ]
Serrano, T. [1 ]
Navas, C. [1 ]
Salazar, R. [1 ]
Villabona, C. [1 ]
Valls, C. [1 ]
Fabregat, J. [1 ]
Condom, E. [1 ]
机构：
[1] Bellvitge Hosp, Dept Patol, Lhospitalet De Llobregat, Spain
来源：
VIRCHOWS ARCHIV | 2014年 / 465卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-09-032
引用
收藏
页码：S211 / S212
页数：2
相关论文
共 50 条
  • [41] Prognostic factors in nonfunctional well-differentiated gastroenteropancreatic neuroendocrine tumors: Single Institute Experience.
    Dogan, Mutlu
    Bal, Oznur
    Kos, Fahriye Tugba
    Zengin, Nurullah
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Well-Differentiated Neuroendocrine of Left Kidney
    Osmani, Asif Husain
    Jaffery, Anis Hussain
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (09): : 1137 - 1138
  • [43] Management of Well-Differentiated Neuroendocrine Tumors
    Tella, Sri Harsha
    Starr, Jason S.
    Kommalapati, Anuhya
    Sonbol, Mohamad Bassam
    Halfdanarson, Thorvardur R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (09) : 582 - 593
  • [44] Single-institution experience with 18F-DOPA and 68Ga-DOTA-TOC as a PET imaging tracer for peptide receptor radionuclide therapy in well-differentiated neuroendocrine neoplasms
    Veenstra, E.
    Noordzij, W.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 199 - 199
  • [45] Updates on well-differentiated neuroendocrine tumors
    Reidy-Lagunes, Diane
    Wyluda, Ed
    SALUD I CIENCIA, 2012, 18 (08): : 737 - 740
  • [46] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Hai-Yan Chen
    Yao Pan
    Jie-Yu Chen
    Lu-lu Liu
    Yong-Bo Yang
    Kai Li
    Ri-Sheng Yu
    Guo-Liang Shao
    European Radiology, 2022, 32 : 8317 - 8325
  • [47] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Chen, Hai-Yan
    Pan, Yao
    Chen, Jie-Yu
    Liu, Lu-lu
    Yang, Yong-Bo
    Li, Kai
    Yu, Ri-Sheng
    Shao, Guo-Liang
    EUROPEAN RADIOLOGY, 2022, 32 (12) : 8317 - 8325
  • [48] Immunohistochemical evaluation of CXCR4 chemokine receptor expression in metastatic and nonmetastatic well-differentiated pancreatic neuroendocrine tumours
    Delektorskaya, V.
    Solovieva, O.
    Patyutko, Y.
    VIRCHOWS ARCHIV, 2019, 475 : S24 - S24
  • [49] [18F]FDG-PET/CT Heterogeneity in Patients with Metastatic, Well-Differentiated Pancreatic Neuroendocrine Tumours
    Ortolani, S.
    Cingarlini, S.
    Citton, E.
    Crosara, S.
    De Robertis, R.
    Grego, E.
    Vallerio, P.
    D'Onofrio, M.
    Butturini, G.
    Landoni, L.
    Capelli, P.
    Zuffante, M.
    Ferdeghini, M.
    Salgarello, M.
    Tortora, G.
    NEUROENDOCRINOLOGY, 2016, 103 : 61 - 61
  • [50] Ki-67 index of 5% could better predict the clinical prognosis of well-differentiated pancreatic neuroendocrine tumours
    Yuan, Bing
    Shi, Yanfen
    Li, Yuanliang
    Tan, Haidong
    Jiao, Peipei
    Su, Wenting
    Liu, Meng
    Qi, Zhirong
    Tan, Huangying
    Luo, Jie
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (12) : 1708 - 1714
12345